Marizyme, Inc.
MRZM
$0.0003
-$0.0078-96.30%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -74.50% | 57.37% | 138.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -74.50% | 57.37% | 138.82% |
| Cost of Revenue | -- | -100.00% | -84.64% | 100.72% | 312.90% |
| Gross Profit | -- | 100.00% | -60.19% | 39.62% | 94.21% |
| SG&A Expenses | -78.88% | -70.18% | -29.74% | 471.50% | 210.71% |
| Depreciation & Amortization | -48.26% | -42.32% | -48.26% | -0.05% | -0.05% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -73.11% | -68.14% | -37.89% | 266.12% | 118.21% |
| Operating Income | 72.10% | 66.92% | 35.67% | -275.43% | -117.52% |
| Income Before Tax | 92.62% | 81.69% | -143.73% | 58.56% | -1,609.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 92.62% | 81.69% | -143.73% | 58.56% | -1,609.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.62% | 81.69% | -143.73% | 58.56% | -1,609.82% |
| EBIT | 72.10% | 66.92% | 35.67% | -275.43% | -117.52% |
| EBITDA | 73.18% | 68.04% | 34.29% | -305.41% | -129.74% |
| EPS Basic | 97.43% | 94.00% | 24.72% | 67.68% | -1,425.00% |
| Normalized Basic EPS | 95.88% | 94.63% | 26.02% | 507.25% | -1,093.28% |
| EPS Diluted | 97.43% | 94.00% | 24.72% | 67.39% | -1,425.00% |
| Normalized Diluted EPS | 95.88% | 94.63% | 26.02% | 507.25% | -1,093.28% |
| Average Basic Shares Outstanding | 187.68% | 204.77% | 223.36% | 28.21% | 12.21% |
| Average Diluted Shares Outstanding | 187.68% | 204.77% | 223.36% | 28.21% | 12.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |